These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8201694)

  • 1. Flow cytometric bromodeoxyuridine/deoxyribonucleic acid bivariate analysis for predicting tumor invasiveness of upper tract urothelial cancer.
    Miyakawa A; Tachibana M; Nakashima J; Deguchi N; Baba S; Tazaki H
    J Urol; 1994 Jul; 152(1):76-80. PubMed ID: 8201694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
    Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
    J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
    al-Abadi H; Nagel R
    J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in patients with primary transitional cell carcinoma of the upper urinary tract.
    Badalament RA; O'Toole RV; Kenworthy P; Young DC; Keyhani-Rofagha S; Simon J; Perez JF; Drago JR
    J Urol; 1990 Oct; 144(4):859-63. PubMed ID: 2398559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
    Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
    J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of DNA ploidy pattern in transitional cell cancer of the renal pelvis and ureter: continuing follow-up.
    Corrado F; Mannini D; Ferri C; Corrado G; Bertoni F; Bacchini P; Lieber MM; Song JM
    Eur Urol; 1992; 21 Suppl 1():48-50. PubMed ID: 1425836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis.
    Corrado F; Ferri C; Mannini D; Corrado G; Bertoni F; Bacchini P; Lelli G; Lieber MM; Song JM
    J Urol; 1991 Jun; 145(6):1159-63. PubMed ID: 2033684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors of primary transitional cell carcinoma of the upper urinary tract.
    Lee SH; Lin JS; Tzai TS; Chow NH; Tong YC; Yang WH; Chang CC; Cheng HL
    Eur Urol; 1996; 29(3):266-70; discussion 271. PubMed ID: 8740029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromodeoxyuridine and deoxyribonucleic acid bivariate analysis in human renal cell carcinoma. Does flow cytometric determination predict malignant potential or prognosis of patients with renal cell carcinoma?
    Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
    Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S38-47. PubMed ID: 1575219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
    Miyakawa A; Tachibana M; Tazaki H
    Cancer Detect Prev; 1995; 19(2):165-72. PubMed ID: 7750104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transitional cell carcinoma of the renal pelvis and ureter in Taiwan. DNA analysis by flow cytometry.
    Chiang PH; Huang MS; Tsai CJ; Tsai EM; Huang CH; Chiang CP
    Cancer; 1993 Jun; 71(12):3988-92. PubMed ID: 8508364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance of DNA ploidy and proliferative activity in urothelial carcinoma of the renal pelvis and ureter. A study on a follow-up period of 6 years.
    Borgmann V; al-Abadi H; Nagel R
    Urol Int; 1991; 47(1):7-11. PubMed ID: 1871915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA; Krane LS; Hemal AK
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow DNA analysis in the characterization of carcinoma of the renal pelvis and ureter.
    Oldbring J; Hellsten S; Lindholm K; Mikulowski P; Tribukait B
    Cancer; 1989 Nov; 64(10):2141-5. PubMed ID: 2804903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter. Relation to tumor proliferation and survival.
    Rey A; Lara PC; Redondo E; Valdés E; Apolinario R
    Cancer; 1997 Jun; 79(11):2178-85. PubMed ID: 9179065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of cell kinetic characteristics using flow cytometric measurements of deoxyribonucleic acid and bromodeoxyuridine for bladder cancer.
    Tachibana M; Deguchi N; Jitsukawa S; Baba S; Hata M; Tazaki H
    J Urol; 1991 May; 145(5):963-7. PubMed ID: 2016810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.